Elevated plasma free fatty acids predict sudden cardiac death:: a 6.85-year follow-up of 3315 patients after coronary angiography

被引:69
作者
Pilz, Stefan
Scharnagl, Hubert
Tiran, Beate
Wellnitz, Britta
Seelhorst, Ursula
Boehm, Bernhard O.
Maerz, Winfried [1 ]
机构
[1] Synlab Ctr Lab Diagnost, D-69031 Heidelberg, Germany
[2] Med Univ Graz, Div Endocrinol & Nucl Med, Dept Internal Med, Graz, Austria
[3] Med Univ Graz, Inst Clin Med, Graz, Austria
[4] Med Univ Graz, Chem Lab Diagnost, Graz, Austria
[5] LURIC Study Nonprofit LLC, Freiburg, Germany
[6] Univ Ulm, Grad Sch Mol Diabetol & Endocrinol, Div Endocrinol & Diabet, D-89069 Ulm, Germany
关键词
free fatty acids; NEFA; sudden cardiac death; epidemiology; mortality;
D O I
10.1093/eurheartj/ehm343
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Sudden cardiac death (SCD) is the most common fatal cardiovascular event. Free fatty acids (FFAs) exert several harmful effects on the myocardium and may therefore contribute to SCD. We examined whether fasting FFA predict SCD in patients who had undergone coronary angiography. Methods and results FFAs were measured at baseline (1997-2000) in 3315 patients scheduled for coronary angiography. Angiographic coronary artery disease was found in 2231 study participants. After a median time of follow-up of 6.85 years, 165 SCD occurred in the entire study population. In a Cox proportional hazards model, the unadjusted hazard ratio (HR) for SCD in the fourth when compared with the first FFA quartile was 2.95 (95% CI 1.84-4.73; P < 0.001). After adjustment for common and emerging cardiovascular risk factors, the HR remained significant at 1.76 (1.03-3.00; P = 0.038). High FFA levels were also significantly associated with all-cause and cardiovascular mortality, even after exclusion of patients with SCD. Conclusion Our study shows that elevated plasma FFAs are an independent risk factor for future SCD in patients referred to coronary angiography. These results may suggest that modulation of myocardial fatty acid uptake and/ or metabolism are a possible target of treatment, but it still remains to be clarified whether high FFA levels are a cause or a consequence of pathological processes that underlie the association between FFA and SCD.
引用
收藏
页码:2763 / 2769
页数:7
相关论文
共 34 条
[1]   Unbound free fatty acids and heart-type fatty acid-binding protein: Diagnostic assays and clinical applications [J].
Azzazy, HME ;
Pelsers, MMAL ;
Christenson, RH .
CLINICAL CHEMISTRY, 2006, 52 (01) :19-29
[2]   Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans [J].
Birkenfeld, AL ;
Boschmann, M ;
Moro, C ;
Adams, F ;
Heusser, K ;
Franke, G ;
Berlan, M ;
Luft, FC ;
Lafontan, M ;
Jordan, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (06) :3622-3628
[3]   Fatty acid metabolism in obesity and type 2 diabetes mellitus [J].
Blaak, EE .
PROCEEDINGS OF THE NUTRITION SOCIETY, 2003, 62 (03) :753-760
[4]  
Charles MA, 2001, AM J EPIDEMIOL, V153, P292, DOI 10.1093/aje/153.3.292
[5]   Current burden of sudden cardiac death: Multiple source surveillance versus retrospective death certificate-based review in a large US community [J].
Chugh, SS ;
Jui, J ;
Gunson, K ;
Stecker, EC ;
John, BT ;
Thompson, B ;
Ilias, N ;
Vickers, C ;
Dogra, V ;
Daya, M ;
Kron, J ;
Zheng, ZJ ;
Mensah, G ;
McAnulty, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (06) :1268-1275
[6]  
FAGASSO G, 2006, EUR HEART J, V27, P942
[7]   Fatty acid oxidation inhibitors in the management of chronic complications of atherosclerosis [J].
Folmes C.D.L. ;
Clanachan A.S. ;
Lopaschuk G.D. .
Current Atherosclerosis Reports, 2005, 7 (1) :63-70
[8]   A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure [J].
Fragasso, Gabriele ;
Palloshi, Altin ;
Puccetti, Patrizia ;
Silipigni, Carmen ;
Rossodivita, Alessandra ;
Pala, Mariagrazia ;
Calori, Giliola ;
Alfieri, Ottavio ;
Margonato, Alberto .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (05) :992-998
[9]   Plasma non-esterified fatty acids: why are we not measuring them routinely? [J].
Frayn, KN .
ANNALS OF CLINICAL BIOCHEMISTRY, 2005, 42 :413-414
[10]   Adipose tissue fatty acid metabolism and cardiovascular disease [J].
Frayn, KN ;
Fielding, BA ;
Karpe, F .
CURRENT OPINION IN LIPIDOLOGY, 2005, 16 (04) :409-415